The table below shows CollPlant Biotechnologies Ltd's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$2.37M
$515.00K
$10.96M
$299.00K
$15.64M
$6.14M
Cost of revenue
$835.00K
$1.63M
$1.99M
$400.00K
$2.00M
$3.00M
Gross profit
$1.54M
-$1.11M
$8.97M
-$101.00K
$13.64M
$3.13M
R&D
$8.19M
$10.52M
$10.48M
$10.26M
$7.63M
$4.07M
CLGN annual revenue (10-K history)
CollPlant Biotechnologies Ltd reported annual revenue of $2.37M for fiscal year 2025. That is up 360.4% from $515.00K in fiscal 2024. Over the 8 fiscal years shown, annual revenue declined from $5.01M (FY 2018) to $2.37M. Figures come from the company's audited annual reports as filed with the SEC.